Besides, higher Src and COX-2 activities are evident in OSCC and are associated with: (a) aggressive tumor behavior; (b) therapy resistance; (c) worse prognosis; (d) possibility of lymph node metastasis; and € poor overall- and disease-free survival rates (Karunakaran and Muniyan 2020). The gene discussed is PTGS2; the disease is neoplasm.